Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The AceI efflux transporter is a membrane protein originally identified in Acinetobacter baumannii that functions as the prototype of the proteobacterial antimicrobial compound efflux (PACE) family of transporters. It actively exports a range of antiseptics (notably chlorhexidine, benzalkonium, dequalinium, proflavine, and acriflavine), as well as naturally occurring short-chain diamines such as cadaverine and putrescine, using an electrochemical proton gradient as the energy source. The AceI gene is induced in response to the presence of these substrates, providing bacteria with adaptive resistance and substantially contributing to clinical challenges in treating infections by conferring multidrug resistance. AceI homologs are widespread across Proteobacteria, defining a new family of efflux pumps distinct from previously known multidrug transporter families[2][3][5][6][7].
Active efflux of antibacterial and biocidal agents, reducing their intracellular concentration; Proton gradient-driven antiport (uses proton motive force to transport substrates out of the cell); Direct binding and transport of specific substrates
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on AceI efflux transporter (AceI).